Neurogene Inc. · NASDAQ:NGNE
Balyasny Asset Management L.P. reported a 5.18% stake in Neurogene Inc. (Schedule 13G)
Event Jun 30, 2026 · Filed Aug 14, 2026
Balyasny Asset Management L.P. reported a 5.18% stake in Neurogene Inc., 818,706 shares, as a passive investor on Jun 30, 2026. Filed Aug 14, 2026 (Schedule 13G).
- Stake
- 5.18%
- Shares
- 818,706
- Intent
- Passive
- What changed
- Crossed above 5%
- Filed together
- 5 holders
The filing in full
| Holder | Stake | Shares |
|---|---|---|
| BALYASNY ASSET MANAGEMENT L.P. | 5.18% | 818,706 |
| BAM GP LLC | 5.18% | 818,706 |
| Balyasny Asset Management Holdings LP | 5.18% | 818,706 |
| Dames GP LLC | 5.18% | 818,706 |
| Dmitry Balyasny | 5.18% | 818,706 |
Source
Related
- Neurogene Inc.
- Balyasny Asset Management L.P.
- Neurogene Inc. shareholders
- Schedule 13G · Prudential Financial Inc · Oct 7, 2026
- Schedule 13G · Jennison Associates LLC · Oct 6, 2026
- Form 4 · McMinn Rachel · Oct 2, 2026
- Schedule 13G/A · Redmile Group, LLC · Aug 14, 2026
- Schedule 13G/A · Trails Edge Capital Partners, LP · Aug 14, 2026